Fed Regist. 1998 Nov 12;63(218):63222-53.
The Food and Drug Administration (FDA) is proposing to amend its classification regulations to designate class I devices that are exempt from the premarket notification requirements, subject to certain limitations, and to designate those class I devices that remain subject to premarket notification requirements under the new statutory criteria for premarket notification requirements. The devices FDA is proposing to designate as exempt do not include class I devices that have been previously exempted by regulation from the premarket notification requirements. This action is being taken under the Federal Food, Drug, and Cosmetic Act (the act), as amended by the Medical Device Amendments of 1976 (the 1976 amendments), the Safe Medical Devices Act of 1990 (SMDA), and the Food and Drug Administration Modernization Act of 1997 (FDAMA). FDA is taking this action in order to implement a requirement of FDAMA.
美国食品药品监督管理局(FDA)提议修订其分类法规,指定某些受特定限制但可免于上市前通知要求的I类器械,并根据新的上市前通知要求法定标准,指定仍需遵守上市前通知要求的I类器械。FDA提议指定为豁免的器械不包括此前已通过法规豁免上市前通知要求的I类器械。此行动是根据经1976年《医疗器械修正案》(1976年修正案)、1990年《安全医疗器械法案》(SMDA)和1997年《食品药品管理局现代化法案》(FDAMA)修订的《联邦食品、药品和化妆品法案》(该法案)采取的。FDA采取此行动是为了执行FDAMA的一项要求。